Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

Hepatology - Tập 57 Số 4 - Trang 1333-1342 - 2013
Khayriyyah Mohd Hanafiah1, Justina Groeger2, Abraham D. Flaxman3, Steven Wiersma4
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
2Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
3Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA
4Global Hepatitis Programme, World Health Organization (WHO), Geneva, Switzerland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Global Burden of Disease Hepatitis C Working Group, 2004, Global burden of disease (GBD) for hepatitis C, J Clin Pharmacol, 44, 20, 10.1177/0091270003258669

Perz, 2006, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, J Hepatol, 45, 529, 10.1016/j.jhep.2006.05.013

1997, Hepatitis C: global prevalence, Wkly Epidemiol Rec, 72, 341

1999, Hepatitis C: global prevalence (update), Wkly Epidemiol Rec, 74, 425

Global surveillance and control of hepatitis C, 1999, Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium, J Viral Hepat, 6, 35

Shepard, 2005, Global epidemiology of hepatitis C virus infection, Lancet Infect Dis, 5, 558, 10.1016/S1473-3099(05)70216-4

Kim, 2010, Transforming the current infrastructure for combating HBV and HCV infections, J Fam Pract, 59, S65

Mitchell, 2010, Institute of Medicine recommendations for the prevention and control of hepatitis B and C, HEPATOLOGY, 51, 729, 10.1002/hep.23561

Peters, 2010, Recommendations for prevention, screening, and diagnosis of HBV and HCV infections, J Fam Pract, 59, S29

GBD 2005 Study 2010 http://www.globalburden.org

Flaxman AD Vos T Lim S Murray CJL Integrated Meta-Regression Framework for Descriptive Epidemiology 2013

Jacobsen, 2010, Hepatitis A virus seroprevalence by age and world region, 1990 and 2005, Vaccine, 28, 6653, 10.1016/j.vaccine.2010.08.037

Peng, 2006, Reproducible epidemiologic research, Am J Epidemiol, 163, 783, 10.1093/aje/kwj093

2012, Mortality estimation for national populations: methods and applications

Kuboki, 1999, A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: age and sex-related seroprevalence of anti-HCV antibody, frequency of viremia, biochemical abnormality and histological changes, Liver, 19, 88, 10.1111/j.1478-3231.1999.tb00016.x

Ishibashi, 1996, Prevalence of inhabitants with anti-hepatitis C virus antibody in an area following an acute hepatitis C epidemic: age-and area-related features, J Epidemiol, 6, 1, 10.2188/jea.6.1

Hayashi, 1995, Transmission of hepatitis C virus by health care workers in a rural area of Japan, Am J Gastroenterol, 90, 794

Furusyo, 2000, Lower hepatitis G virus infection prevalence compared to hepatitis B and C virus infection prevalences, Diges Dis Sci, 45, 188, 10.1023/A:1005494301751

Armstrong, 2006, The prevalence of hepatitis C virus infection in the United States, 1999 through 2002, Ann Intern Med, 144, 705, 10.7326/0003-4819-144-10-200605160-00004

Farrugia, 2010, Payment, compensation and replacement-the ethics and motivation of blood and plasma donation, Vox Sang, 99, 202, 10.1111/j.1423-0410.2010.01360.x

Fernandez-Montoya, 1997, Altruism and payment in blood donation, Transfus Sci, 18, 379, 10.1016/S0955-3886(97)00026-X

Albeldawi, 2010, Hepatitis C virus: prevention, screening, and interpretation of assays, Cleve Clin J Med, 77, 616, 10.3949/ccjm.77a.09162

Constantinescu, 1998, “Trial moves rapidly on, when the judge has determined the sentence beforehand” (W. Scott: Ivanhoe, 36) or pitfalls in serosurvey of anti-hepatitis C antibody in children, Rom J Virol, 49, 11

Gelman, 2006, Multilevel (hierarchical) modeling: what it can and cannot do, Technometrics, 48, 432, 10.1198/004017005000000661

Wakefield, 2006, Health-exposure modeling and the ecological fallacy, Biostatistics, 7, 438, 10.1093/biostatistics/kxj017

Wasley, 2000, Epidemiology of hepatitis C: geographic differences and temporal trends, Semin Liver Dis, 20, 1, 10.1055/s-2000-9506

Armstrong, 2000, The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States, HEPATOLOGY, 31, 777, 10.1002/hep.510310332

Maher, 2007, High hepatitis C incidence in new injecting drug users: a policy failure?, Aust N Z J Public Health, 31, 30, 10.1111/j.1753-6405.2007.00007.x

Iversen, 2010, Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008, Int J Drug Policy, 21, 471, 10.1016/j.drugpo.2010.04.004

McIntyre, 2006, Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission, Cochrane Database Syst Revs, CD005546

Yeung, 2001, Mother-to-infant transmission of hepatitis C virus, HEPATOLOGY, 34, 223, 10.1053/jhep.2001.25885

Batash, 2008, High prevalence of hepatitis C virus infection among immigrants from the former Soviet Union in the New York City metropolitan area: results of a community-based screening program, Am J Gastroenterol, 103, 922, 10.1111/j.1572-0241.2008.01789.x

Freeman, 2001, Estimating progression to cirrhosis in chronic hepatitis C virus infection, HEPATOLOGY, 34, 809, 10.1053/jhep.2001.27831

Fu, 2007, Event-biased referral can distort estimation of hepatitis C virus progression rate to cirrhosis, and of prognostic influences, J Clin Epidemiol, 60, 1140, 10.1016/j.jclinepi.2007.01.015

Seeff, 2009, The history of the “natural history” of hepatitis C (1968-2009), Liver Int, 29, 89, 10.1111/j.1478-3231.2008.01927.x